Welcome back to Beatwise The Podcast!

In this episode, I’m thrilled to be joined by Professor Marianna Fontana from the National Amyloidosis Center as we dive deep into the world of cardiac amyloidosis.

Together, we explore this complex condition, breaking down the two main types—ATTR and AL amyloidosis. Professor Fontana brings her knowledge to explain the symptoms and the critical importance of early diagnosis in managing the disease effectively.

We also highlight her leadership in the groundbreaking Helios B study, offering new hope for those suffering from cardiomyopathy. If you’re curious about how clinical trials are shaping the future of amyloidosis treatment, this is an episode you won’t want to miss!

Join us as we explore everything from patient experiences to future breakthroughs, and discover how research is paving the way for better patient outcomes.

Episode Highlights

[00:00] Introduction to Cardiac Amyloidosis

[00:24] Meet Professor Marianna Fontana

[01:05] Understanding Amyloidosis

[02:05] The Types of Cardiac Amyloidosis: ATTR vs. AL

[07:59] Key Symptoms and the Diagnosis Process

[19:08] When and How Patients Are Referred for Treatment

[23:56] The Groundbreaking Helios B Study and Its Impact

[30:07] Insights into Patient Experiences and Future Treatment Directions

[32:30] Conclusion and Final Thoughts

If you enjoyed this episode, please like, rate, and subscribe to Beatwise The Podcast. Your support helps me reach more listeners and continue providing valuable content.

Don't forget to follow me on social media @sarah.theheartdoc for the latest updates, behind-the-scenes content, and more engaging discussions. Stay connected and be part of our growing community!

Disclaimer:

The content of this podcast is for informational purposes only and is not intended as medical advice. Always consult a healthcare professional before making any changes to your diet or health routine.

Hosted on Acast. See acast.com/privacy for more information.